Browse medicines, page 42 of 43

Use listed on the medicine record

The incidence of recurrent vulvovaginal candidiasis

Use listed on the medicine record

Oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug. Cultures and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug. (See CLINICAL PHARMACOLOGY - Susceptibility Test Methods ). Oxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. Oxacillin should not be used in infections caused by organisms susceptible to penicillin G.

Use listed on the medicine record

The topical treatment of the following dermal infections

Use listed on the medicine record

Stop use and ask a doctor if rash occurs. En cas de rougeurs cessez l'utilisationet consultez un medecin. Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. If swallowed, get medical help or contact a Poison Control Center right away. Avertissements À usage externe seulement Ne pas utilisersur une peau abîmée ou des plaies ouvertes Faites attention à vos yeux lorsque vous utilisez ce produit. Nettoyez avec de l’eau. Ne pas laisser à la portée des enfants.

Use listed on the medicine record

Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings

Use listed on the medicine record

Persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment

Use listed on the medicine record

Adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome

Use listed on the medicine record

Acute attacks of hereditary angioedema

Use listed on the medicine record

Bacterial vaginosis

Use listed on the medicine record

The treatment of adult patients with multiple myeloma who have received at least one prior therapy

Use listed on the medicine record

RETEVMO ® is a kinase inhibitor indicated for the treatment of: Adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a rearranged during transfection (RET) gene fusion, as detected by an FDA-approved test ( 1.1 ) Adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, as detected by an FDA-approved test, who require systemic therapy ( 1.2 ) Adult and pediatric patients 2 years of age and older with advanced or metastatic thyroid cancer with a RET gene fusion, as detected by an…

Use listed on the medicine record

KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) [see Dosage and Administration (2) ]. KOSELUGO is a kinase inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). ( 1 )

Use listed on the medicine record

Laxative

Use listed on the medicine record

Hyperphenylalaninemia

Use listed on the medicine record

INDICATIONS & USAGE SECTION Silver Sulfadiazine Cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.

Use listed on the medicine record

INDICATION AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.

Use listed on the medicine record

Sodium Iodide I 131 Capsules Diagnostic is indicated for use in adults for: Assessment of thyroid function using radioactive iodine (RAI) uptake test Imaging the thyroid (scintigraphy) Sodium Iodide I 131 Capsules Diagnostic is a radioactive diagnostic agent indicated for the assessment of thyroid function and for thyroid imaging.

Use listed on the medicine record

Hyperkalemia

Use listed on the medicine record

LUMAKRAS is an inhibitor of the RAS GTPase family indicated for: KRAS G12C-mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) As a single agent, for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy. ( 1.1 ) This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR).

Use listed on the medicine record

Sulfacetamide Sodium Ophthalmic Solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species. Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa .

Use listed on the medicine record

Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Limitations of Use: Use only if a clear diagnosis of migraine or cluster headache has been established. If a patient has no response to the first migraine or cluster headache attack treated with sumatriptan injection, reconsider the diagnosis before sumatriptan injection is administered to treat any subsequent attacks. Sumatriptan injection is not indicated for the prevention of migraine or cluster headache attacks.

Use listed on the medicine record

The cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis

Use listed on the medicine record

Deleterious or suspected deleterious germline BRCA -mutated (g BRCA m) HER2-negative locally advanced or metastatic breast cancer

Use listed on the medicine record

Locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) [see Dosage and Administration ( 2

Use listed on the medicine record

• For the temporary relief of symptoms including: • lack of self control • anger • brain support • control of emotions • rapid thoughts • obsessive thoughts • sadness • fear These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Use listed on the medicine record

The treatment of adult patients

Use listed on the medicine record

Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Gently file the nail to make it thinner and remove debris, being cautious not to harm the nail bed. For best results, file nails every 2-3 days. 2. Supervise children in the use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. To prevent athlete's foot, apply once or twice daily (morning and/or night).

Use listed on the medicine record

Edema associated with heart failure, renal disease or hepatic disease

Use listed on the medicine record

USAGE After wetting your face with lukewarm water,dispense an adequate amount into your palm.Gently massage over the skin to release the rich,silky foam, allowing Tremella Fuciformis extract,fermented soybean actives, and revitalizingpeptides to deeply cleanse while preservingmoisture. Rinse thoroughly and pat dry. Usemorning and evening for a refreshed,comfortable complexion.

Use listed on the medicine record

GRAFAPEX is an alkylating drug indicated for: Use in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult and pediatric patients 1 year of age and older with acute myeloid leukemia (AML). ( 1.1 ). Use in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in adult and pediatric patients 1 year of age and older with myelodysplastic syndrome (MDS). ( 1.2 ).

Use listed on the medicine record

Pulmonary arterial hypertension (PAH